Advisornet Financial’s Ascendis Pharma A/S ASND Stock Holding History

Advisornet Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-34	Closed	-$3K	–	1859
2022 Q2	$3K	Hold	34	–	–	﹤0.01%	1594
2022 Q1	$4K	Buy	+34	New	+$3.94K	﹤0.01%	1647

Other funds holding ASND

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Advisornet Financial's ASND Position: Q3 2022 in Review

Advisornet Financial sold out of Ascendis Pharma A/S (ASND) in Q3 2022, closing a stake of 34 shares — an estimated $3K sold.

Advisornet Financial first reported a position in ASND in Q1 2022 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 183 funds tracked by Wall St. Rank hold ASND as of Q3 2022.

Advisornet Financial reported no remaining Ascendis Pharma A/S position as of Q3 2022 after selling out during the quarter.
Advisornet Financial sold 34 Ascendis Pharma A/S shares in Q3 2022, an estimated $3K.
Advisornet Financial first reported a position in Ascendis Pharma A/S in Q1 2022 and held it in 2 quarters.
Advisornet Financial's Ascendis Pharma A/S position peaked at $4K in Q1 2022.
183 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2022.

Based on Advisornet Financial's 13F filing for Q3 2022, filed 4 Oct 2022.